Now showing items 1-4 of 4

    • Advancement of Antibody-Drug conjugates in cancer treatment: A review 

      Sagar, Baejid Hossain (Brac University, 2022-01)
      Antibody-drug conjugates (ADCs) are a rapidly growing class of biotherapeutic, targeted to selectively introduce cytotoxic agents into the cancer cell by means of monoclonal antibodies. USFDA has approved ten ADCs till ...
    • Concepts and challenges of biosimilars to mitigate the oncology drug expenses 

      Tania, Umme (Brac University, 2021-02)
      Biosimilars is way more likely to genuine generic drugs of the innovator. Time to time expiry of generic drugs helps manufacturer to think about biosimilars which has wide cost effectiveness as well as expanded patient ...
    • Immunotherapeutic approaches to treat cancer: Prospects and challenges 

      Fred, Namanda Rogers (Brac University, 2021-05)
      This review examines and summarizes major novel immunotherapeutic modalities used in cancer immunotherapy that are currently approved or in clinical trials, as well as their therapeutic potential, side effects, challenges, ...
    • Post Covid-19 health indications of Covid-19 patients 

      Khan, Tanzim (Brac University, 2022-05)
      This study was designed in such a way so that it can focus on how patients can express or understand their post covid indications that are being faced by them. The sample size was determined by using Raosoft sampling method ...